bosentan anhydrous has been researched along with Thromboembolism in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 9 (75.00) | 29.6817 |
2010's | 3 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cebotari, S; Hoeper, MM; Madani, MM; Meyer, B; Nakanishi, N; Rubin, LJ | 1 |
D'Armini, AM; Delcroix, M; Ghofrani, HA; Hoeper, MM; Jaïs, X; Jansa, P; Lang, IM; Mayer, E; Morganti, A; Pepke-Zaba, J; Perchenet, L; Rubin, LJ; Simonneau, G; Torbicki, A | 1 |
Bresser, P; Fedullo, PF; Kloek, JJ; Reesink, HJ; Surie, S; Tan, HL; Tepaske, R | 1 |
Confalonieri, M; Kodric, M; Longo, C; Vassallo, FG | 1 |
Bauleo, C; Catapano, G; Formichi, B; Genovesi, D; Giuntini, C; Mannucci, F; Marini, C; Michelassi, C; Monti, S; Prediletto, R | 1 |
Cafferty, F; Dunning, J; George, P; Hughes, R; Morrell, NW; Parameshwar, J; Pepke-Zaba, J | 1 |
Hoeper, MM; Kramm, T; Mayer, E; Schäfers, HJ; Schulze, C; Welte, T; Wilkens, H | 1 |
Adlbrecht, C; Bonderman, D; Jakowitsch, J; Klepetko, W; Lang, IM; Nowotny, R; Skoro-Sajer, N | 1 |
Kashour, T; Philipp, R; Sharma, S | 1 |
Bonderman, D; Hughes, RJ; Humbert, M; Jais, X; Lang, I; Pepke-Zaba, J; Simonneau, G; Suntharalingam, J | 1 |
Hammerschmidt, S; Pankau, H; Seyfarth, HJ; Winkler, J; Wirtz, H | 1 |
Almeida, AR; Almeida, S; Carrageta, M; Cordeiro, P; Cotrim, C; Loureiro, MJ; Miranda, R; Simões, O | 1 |
2 review(s) available for bosentan anhydrous and Thromboembolism
Article | Year |
---|---|
Chronic thromboembolic pulmonary hypertension.
Topics: Angioplasty, Balloon; Bosentan; Chronic Disease; Endarterectomy; Endothelin Receptor Antagonists; Enzyme Activators; Humans; Hypertension, Pulmonary; Phosphodiesterase 5 Inhibitors; Piperazines; Pulmonary Embolism; Purines; Pyrazoles; Pyrimidines; Sildenafil Citrate; Sulfonamides; Thromboembolism | 2014 |
Bosentan for chronic thromboembolic pulmonary hypertension.
Topics: Antihypertensive Agents; Bosentan; Chronic Disease; Endothelin Receptor Antagonists; Humans; Hypertension, Pulmonary; Sulfonamides; Thromboembolism | 2009 |
4 trial(s) available for bosentan anhydrous and Thromboembolism
Article | Year |
---|---|
Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial.
Topics: Antihypertensive Agents; Bosentan; Chronic Disease; Disease Progression; Double-Blind Method; Endarterectomy; Endothelin Receptor Antagonists; Exercise Tolerance; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Middle Aged; Prognosis; Severity of Illness Index; Sulfonamides; Thromboembolism | 2008 |
Bosentan as a bridge to pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.
Topics: Aged; Antihypertensive Agents; Bosentan; Endarterectomy; Female; Humans; Hypertension, Pulmonary; Male; Middle Aged; Sulfonamides; Thromboembolism | 2010 |
Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension.
Topics: Aged; Anticoagulants; Antihypertensive Agents; Bosentan; Diuretics; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Middle Aged; Natriuretic Peptide, Brain; Oxygen Consumption; Pilot Projects; Sulfonamides; Thromboembolism; Vascular Resistance; Walking | 2005 |
Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension.
Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Antihypertensive Agents; Aspartate Aminotransferases; Bosentan; Endothelin Receptor Antagonists; Exercise Test; Female; Follow-Up Studies; Humans; Hypertension, Pulmonary; Liver Function Tests; Male; Middle Aged; Sulfonamides; Thromboembolism; Walking | 2005 |
6 other study(ies) available for bosentan anhydrous and Thromboembolism
Article | Year |
---|---|
Improved survival in patients with inoperable chronic thromboembolic pulmonary hypertension.
Topics: Acid-Base Equilibrium; Aged; Antihypertensive Agents; Blood Gas Analysis; Bosentan; Cardiac Output; Chronic Disease; Drug Therapy, Combination; Exercise Test; Female; Humans; Hypertension, Pulmonary; Isoxazoles; Male; Middle Aged; Oxygen Consumption; Oxygen Inhalation Therapy; Piperazines; Purines; Severity of Illness Index; Sildenafil Citrate; Sulfonamides; Sulfones; Survival Rate; Thiophenes; Thromboembolism; Treatment Outcome; Vascular Resistance; Vasodilator Agents | 2013 |
Bosentan in inoperable chronic thromboembolic pulmonary hypertension.
Topics: Antihypertensive Agents; Bosentan; Humans; Hypertension, Pulmonary; Sulfonamides; Thromboembolism | 2005 |
Secondary pulmonary arterial hypertension: treated with endothelin receptor blockade.
Topics: Aged; Antihypertensive Agents; Bosentan; Endothelin Receptor Antagonists; Female; Follow-Up Studies; Humans; Hypertension, Pulmonary; Lupus Erythematosus, Systemic; Male; Middle Aged; Pulmonary Wedge Pressure; Receptors, Endothelin; Sarcoidosis, Pulmonary; Scleroderma, Systemic; Sulfonamides; Thromboembolism | 2005 |
The efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension: a 1-year follow-up study.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Antihypertensive Agents; Bosentan; Disease Progression; Female; Follow-Up Studies; Humans; Hypertension, Pulmonary; Male; Middle Aged; Retrospective Studies; Sulfonamides; Thromboembolism; Time Factors; Treatment Outcome | 2006 |
Long-term bosentan in chronic thromboembolic pulmonary hypertension.
Topics: Antihypertensive Agents; Bosentan; Chronic Disease; Exercise Tolerance; Female; Follow-Up Studies; Humans; Hypertension, Pulmonary; Kaplan-Meier Estimate; Male; Prospective Studies; Sulfonamides; Thromboembolism; Treatment Outcome; Ventricular Function, Right | 2007 |
Should right ventricle dilatation during exercise have clinical implications in patients with chronic thromboembolic pulmonary hypertension? Case report.
Topics: Adult; Antihypertensive Agents; Bosentan; Cardiac Catheterization; Dilatation, Pathologic; Echocardiography, Doppler; Exercise Test; Female; Humans; Hypertension, Pulmonary; Piperazines; Purines; Sildenafil Citrate; Sulfonamides; Sulfones; Thromboembolism; Vascular Resistance; Vasodilator Agents; Ventricular Dysfunction, Right | 2007 |